Stock data

視陽 (6782)

視陽 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$495.17M, up 14.9% from a year earlier. EPS over the last four quarters totals NT$16.49.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 視陽 in Insightr